Identification of predictive circulating biomarkers of bevacizumab-containing regimen efficacy in pre-treated metastatic colorectal cancer patients

Identification of predictive circulating biomarkers of bevacizumab-containing regimen efficacy in pre-treated metastatic colorectal cancer patients

BACKGROUND: To identify whether circulating levels of angiogenesis-related factors may be predictive of bevacizumab efficacy in pre-treated metastatic colorectal cancer (mCRC) patients. METHODS: Pre-treatment serum levels of 24 cytokines were measured using a multiplex bead assay (MBA) in 32 pre-...

Full description

Bibliographic Details
Main Authors: Abajo, A. (Ana), Boni, V. (Valentina), Lopez, I. (Inés), Gonzalez-Huarriz, M. (Marisol), Bitarte, N. (Nerea), Rodriguez, J. (Javier), Zarate, R. (Ruth), Bandres, E. (Eva), Garcia-Foncillas, J. (Jesús)
Format: info:eu-repo/semantics/article
Language:eng
Published: Nature 2014
Subjects:
Bevacizumab
Serum biomarkers
Colorectal cancer
Multiplex bead assays
Online Access:https://hdl.handle.net/10171/36169

Internet

https://hdl.handle.net/10171/36169

Similar Items